Biological Efficacy of Clopidogrel 600 mg Loading Dose Followed by 75 mg Maintenance Dose After Implantation of Drug-eluting Stents in Patients With Diabetes Mellitus or Metabolic Syndrome (SPACE).
Phase of Trial: Phase III
Latest Information Update: 23 Sep 2011
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary thrombosis; Myocardial ischaemia
- Focus Pharmacodynamics
- Acronyms SPACE
- 31 Aug 2018 Biomarkers information updated
- 27 Jun 2011 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.